Navigation Links
Therapy Modulates Highly Sensitized Immune System to Let Mother Give Kidney to Daughter

As the holidays approached last year, Soraya Kohanzadeh, 30, Muir Beach, CA, was living day to day, extremely ill, with no hope and expecting to live a shortened life// dependent on kidney dialysis. She needed a kidney transplant but because her “anti-donor” antibody levels were so high, her doctors believed that a transplant was not possible – perhaps ever. However, thanks to a specialized type of anti-rejection therapy pioneered at Cedars-Sinai Medical Center, Soraya successfully underwent a transplant in May of this year and has a “new lease on life” as she looks forward to 2007.

Soraya, was among the estimated 33 percent of kidney failure patients who have high “anti-donor” antibody levels and who are often told that a transplant is not possible even if a potential donor’s tissue and blood types otherwise match perfectly.

But on May 16, 2006, she received a kidney donated by her mother, Joan Lando, at Cedars-Sinai . The transplanted kidney started working immediately, both patients recovered well, and Soraya has had no episodes of rejection – the result of a therapy that makes the incompatible compatible and the impossible a reality in many cases.

Soraya had expected to live a shortened life, dependent on kidney dialysis -- a painful, expensive, time-consuming procedure that cleans blood well enough to maintain existence but not well enough to contribute to quality of life.

Physicians in the San Francisco area said transplantation was not an option because a donor organ would be rejected by her hyper-vigilant immune system – a prospect faced by about one-third of the more than 70,000 patients on the nation’s kidney transplant waiting lists. But Soraya conducted an Internet search and found that Cedars-Sinai is one of the very few centers in the nation addressing this problem.

Tissue compatibility issues exist for all patients receiving transplanted organs, but rejection risks are dramatically increased
'"/>




Page: 1 2 3 4

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis

Post Your Comments:
(Date:12/4/2009)...kDesk Inventor Showcasing Innovative Health Produc... December 4, 2009 -- A valley inventor garnering n... individuals lose weight, prevent disease, restore...be showcasing the product at Saturday’s Tech..., , , , TrekDesk has been featured on major tele...
(Date:12/4/2009)... Fla., Dec. 4 NeoGenom...oday that Steven C. Jones has been appointed Execu...rdoza has joined the company as Chief Financial Of...ng all internal financial affairs of the Company. ...ng strategic initiatives on behalf of NeoGenomics ...
(Date:12/4/2009)... 4 The following is an ...amily Philanthropies: ,, Credit Senators John K...cant contribution to the health care debate: a bil...ving with Phenylketonuria (PKU) control their pote...ving with serious chronic conditions are treated. ...
(Date:12/4/2009)...her pollution levels, though risks are unclear , ...orporate and private jets take off and land at sma...st fills the air with small particles of combustio...arby, suggests a new study by California researche...ized as a problem near major airports, far less re...
(Date:12/4/2009)...la., Dec. 4 , ,What: Hum...edicare, health benefits provider, i...managames.com ), a senior-friendly dance pad, ...ter on Tues., Dec. 8 at 1 p.m. The ... and open to the public, will feature Dancetown, ...
Breaking Medicine News(10 mins):Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:NeoGenomics Announces Executive Appointments 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Smaller Airports May Endanger Health 2Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2
...oration (Nasdaq: RURL ) issued another reminder t...re of the Company,s common stock in relation,to it...rship rules under,Section 382 of the U.S. Internal...ng a change in ownership of,the corporation. Secti...
...ocial Security Disability Insurance Should Know Th... Questions , Belleville, ...ves with a mental or physical disability face many...ges, the past still plays a role in the future, es...
...ecialists, a leader in Cardiology and Gastroentero...;s leading provider of medical transcription servi...ical transcription provider for accurate and timel...cal transcription services to healthcare clinics, ...
... percentage of African American ...Keeping a food diary can double,a person,s weight ... Center,for Health Research. The findings, from on...reventive Medicine., Funded by the National Heart...
...l months,senior leadership at Anthem Blue Cross ha...with the California Department of Managed Health C...vious rescissions. I,personally have been negotiat... are the key elements of our settlement proposal:,...
...,("Ventas" or the "Company") announced today that ...ease after the close of trading on Tuesday,August ...gs will be held on,Wednesday, August 6, 2008 at 10...asreit.com or at, http://www.earnings.com ., Ven...
Other Medicine News:Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 2Health News:Rural/Metro Issues Reminder to Stockholders on Transactions That May Impact IRS Section 382 Outcome 3Health News:Past Earnings Play Role in Determining SSDI Benefits 2Health News:Past Earnings Play Role in Determining SSDI Benefits 3Health News:Past Earnings Play Role in Determining SSDI Benefits 4Health News:Past Earnings Play Role in Determining SSDI Benefits 5Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 2Health News:Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider. 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 2Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 3Health News:Kaiser Permanente Study Finds Keeping a Food Diary Doubles Diet Weight Loss 4Health News:Anthem Blue Cross Statement on Settlement Discussions with the California Department of Managed Health Care 2
(Date:12/3/2009)..., , NEW YORK, Dec. 3 Gu...firm, today announced the launch of their Sleep Ap...hat monitors and projects trends and market share ...eep Apnea Tracker captures actual patient usage fo... United States from 15 different equipment provide...
(Date:12/3/2009)..., , SUNNYVALE, Calif., Dec. 3 /PRNewswir... ), a biopharmaceutical company focused on develop...drugs for the treatment of immune mediated disease...webcast and conference call on, Tuesday, December ...ime and 8:00am Pacific Time) to discuss clinical d...
(Date:12/3/2009)..., , WILMINGTON, Del., Dec. 3 /PRNewswir...zing in pharmaceutical risk management and optimal...sday, Dec. 9, on the FDA,s draft guidance on REMS ...nd its implications for REMS lifecycle management....nRx and an expert on REMS and risk management prog...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2PharmSource Releases White Paper on Role of U S Foreign Corrupt Practices Act 28FCPA 29 in the Bio Pharma Industry 12931 1PharmSource Releases White Paper on Role of U S Foreign Corrupt Practices Act 28FCPA 29 in the Bio Pharma Industry 12931 2PharmSource Releases White Paper on Role of U S Foreign Corrupt Practices Act 28FCPA 29 in the Bio Pharma Industry 12931 3Vancouver Fertility Acupuncture Clinic Announces New Fellows of the American Board of Oriental Reproductive Medicine 51025 1Vancouver Fertility Acupuncture Clinic Announces New Fellows of the American Board of Oriental Reproductive Medicine 51025 2Vancouver Fertility Acupuncture Clinic Announces New Fellows of the American Board of Oriental Reproductive Medicine 51025 3New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product 51020 1New York Law Firm Files Lawsuit Against Manufacturer of Zicam Nasal Spray and Drugstore Chain That Sold Product 51020 2
...EL, Switzerland, April 3, 2007 (PRIME NEWSWIRE) --...iological and,pharmacokinetic profiles of Basilea,...iprole and isavuconazole. Studies reported,both fo...,cephalosporin in late-stage development, and for ...invasive fungal infections,yielded further data o...
...Y, France, April 04, 2007 /PRNewswire/ -- Novagali...pany specialized in,ophthalmology, announces today...y of Vekacia(R) in children suffering from Vernal,..., it was shown,that both symptoms and signs of dis...rthermore, the tolerability to Vekacia(R),was exce...
Other Medicine Technology:Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 2Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 3Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 4Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 5Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 6Scientific Results Presented At ECCMID Demonstrate Well-,Differentiated Profile of Basilea's Two Phase III Anti- infective,Compounds 7Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2
Genu-Lite Knee Support
GenuTrain
Exotec® Dual Instabilities Lite
...atellar Brace is a support designed to treat patel... aircell stabilizes the patella and compresses the... the patella. During ambulation, the aircell also ...welling and pain. A moveable aircell is included t...
Medicine Products: